Brief: Instil Bio Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Corporate Update
31/03/2023 12:12
March 31 (Reuters) - Instil Bio Inc TIL.O :
* INSTIL BIO REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* INSTIL BIO INC - INSTIL CONFIRMS CASH RUNWAY BEYOND 2026
* INSTIL BIO INC - ANTICIPATE INITIAL CLINICAL DATA FROM
ITIL-306
PHASE 1 PROGRAM IN 2024
* INSTIL BIO INC - QTRLY LOSS PER SHARE $ 0.41
Source text for Eikon: ID:nGNXbBmR8k
Further company coverage: TIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Instil Bio
See all newsInstil Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Instil Bio Q2 net loss narrows on lower R&D spending, restructuring charges
Brief: Instil Bio Q2 Basic EPS USD -0.63
Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio Q1 net loss narrows on lower R&D expenses